Authors’ Response to Comment on “Efficacy and Safety of Subcutaneous Esketamine in the Treatment of Suicidality in Major Depressive Disorder and Bipolar Depression”
CLINICAL DRUG INVESTIGATION（2022）
Key words
subcutaneous esketamine,bipolar depression”,major depressive disorder,suicidality
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined